ECOG-ACRIN EAY131-H

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol H: Phase II Study of Dabrafenib and Trametinib in Patients with Tumors with BRAF V600E or V600K Mutations (Excluding Melanoma and Thyroid Cancer)

 

(See required screening study ECOG-ACRIN EAY131)

Effective immediately, 06/15/18, EAY131-H is formally closed to accrual, as it has reached its enrollment goal.

NCT#02465060